Pharmaceuticals

QSOX1 as an anti-neoplastic drug target

ErbB4 Inhibitors and Methods of Use

Compositions for Treatment of HER2 Positive Cancers

Diazeniumdiolate Derivative Anti-Cancer Agents

A Novel Immunotherapy for Treating Glioblastoma Multiforme

Machine Learning for Aptamer Design and Analysis

Compounds to Modulate Retinoid X Receptors

Compositions for Treatment of HER2 Positive Cancers

Metabolite Delivery for Modulating Metabolic Pathways of Cells

Neutrophil based CAR Therapies for Treatment